Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (341-350 of 753) with videos related to

Pageof 76
Sort By:
Lancet (London, England)|September 27, 2005
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass indexMarco Colleoni, Sigui Li, Richard D Gelber, et al.
Journal of the National Cancer Institute|May 4, 2000
Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patientsE Munzone, F Nolé, L Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapyG Curigliano, V Formica, T De Pas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancerF Nolè, C Catania, G Sanna, et al.
Ecancermedicalscience|January 26, 2012
Correlation between administered treatment and patient's living willB Andreoni, A Goldhirsch, R Orecchia, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerF Cavalli, A Pedrazzini, G Martz, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.
Oncology Reports|May 19, 2011
Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumorsM Colleoni, R Graffeo, G Martinelli, et al.
Oncotarget|June 21, 2016
Impact of autoimmune diseases on outcome of patients with early breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Angela Esposito, et al.
The Lancet. Oncology|May 21, 2018
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Pageof 76

Showing results (341-350 of 753) with videos related to

Sort By:
Pageof 76
Lancet (London, England)|September 27, 2005
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass indexMarco Colleoni, Sigui Li, Richard D Gelber, et al.
Journal of the National Cancer Institute|May 4, 2000
Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patientsE Munzone, F Nolé, L Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapyG Curigliano, V Formica, T De Pas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancerF Nolè, C Catania, G Sanna, et al.
Ecancermedicalscience|January 26, 2012
Correlation between administered treatment and patient's living willB Andreoni, A Goldhirsch, R Orecchia, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerF Cavalli, A Pedrazzini, G Martz, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.
Oncology Reports|May 19, 2011
Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumorsM Colleoni, R Graffeo, G Martinelli, et al.
Oncotarget|June 21, 2016
Impact of autoimmune diseases on outcome of patients with early breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Angela Esposito, et al.
The Lancet. Oncology|May 21, 2018
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Pageof 76